Maryland State Retirement & Pension System Has $1.43 Million Stock Position in Humana Inc. $HUM

Maryland State Retirement & Pension System lifted its position in shares of Humana Inc. (NYSE:HUM) by 4.1% in the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 5,867 shares of the insurance provider’s stock after buying an additional 231 shares during the quarter. Maryland State Retirement & Pension System’s holdings in Humana were worth $1,434,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Venturi Wealth Management LLC acquired a new position in shares of Humana during the 2nd quarter worth approximately $218,000. KLP Kapitalforvaltning AS boosted its stake in shares of Humana by 6.5% in the second quarter. KLP Kapitalforvaltning AS now owns 44,370 shares of the insurance provider’s stock valued at $10,881,000 after buying an additional 2,700 shares during the period. Prime Capital Investment Advisors LLC boosted its stake in shares of Humana by 10.6% in the second quarter. Prime Capital Investment Advisors LLC now owns 953 shares of the insurance provider’s stock valued at $233,000 after buying an additional 91 shares during the period. Sendero Wealth Management LLC boosted its stake in shares of Humana by 28.2% in the second quarter. Sendero Wealth Management LLC now owns 4,440 shares of the insurance provider’s stock valued at $1,085,000 after buying an additional 978 shares during the period. Finally, Willner & Heller LLC raised its holdings in Humana by 23.5% in the 2nd quarter. Willner & Heller LLC now owns 2,180 shares of the insurance provider’s stock valued at $533,000 after acquiring an additional 415 shares in the last quarter. 92.38% of the stock is owned by institutional investors.

Humana Stock Down 3.6%

HUM stock opened at $280.24 on Friday. The firm has a 50-day moving average price of $279.45 and a 200-day moving average price of $258.13. The stock has a market capitalization of $33.70 billion, a P/E ratio of 21.51, a price-to-earnings-growth ratio of 1.65 and a beta of 0.42. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $315.35. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.3%. Humana’s dividend payout ratio (DPR) is currently 27.17%.

Analyst Ratings Changes

HUM has been the subject of several analyst reports. Bank of America lifted their price objective on Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a report on Friday. Guggenheim reiterated a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Truist Financial reduced their price objective on shares of Humana from $280.00 to $260.00 and set a “hold” rating on the stock in a research note on Wednesday, July 16th. Royal Bank Of Canada upped their price target on shares of Humana from $283.00 to $322.00 and gave the stock an “outperform” rating in a report on Thursday, August 21st. Finally, Evercore ISI assumed coverage on shares of Humana in a report on Monday, September 22nd. They set an “in-line” rating and a $295.00 price target for the company. Seven research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average price target of $298.00.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.